AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
Operational & Financial Ratios | |||
Earnings Per Share (Rs) | 21.35 | 4,890.04 | -0.18 |
CEPS(Rs) | 28.25 | 6,574.79 | -0.18 |
DPS(Rs) | 2.00 | - | - |
Book NAV/Share(Rs) | 171.97 | 53,646.60 | 9.12 |
Tax Rate(%) | 25.80 | 21.32 | - |
Margin Ratios | |||
Core EBITDA Margin(%) | 17.58 | 17.11 | - |
EBIT Margin(%) | 14.49 | 13.95 | - |
Pre Tax Margin(%) | 13.41 | 12.95 | - |
PAT Margin (%) | 9.95 | 10.19 | - |
Cash Profit Margin (%) | 13.16 | 13.70 | - |
Performance Ratios | |||
ROA(%) | 9.06 | 11.98 | -1.84 |
ROE(%) | 13.35 | 18.23 | -2.02 |
ROCE(%) | 16.11 | 19.40 | -1.87 |
Asset Turnover(x) | 0.91 | 1.18 | - |
Sales/Fixed Asset(x) | 1.46 | 0.98 | - |
Working Capital/Sales(x) | 3.45 | 2.68 | - |
Efficiency Ratios | |||
Fixed Capital/Sales(x) | 0.68 | 1.02 | - |
Receivable days | 76.62 | 114.57 | - |
Inventory Days | 101.09 | 144.62 | - |
Payable days | 100.85 | 61.41 | - |
Valuation Parameters | |||
PER(x) | 12.86 | - | - |
PCE(x) | 9.72 | - | - |
Price/Book(x) | 1.60 | - | - |
Yield(%) | 0.73 | - | - |
EV/Net Sales(x) | 1.38 | 0.21 | - |
EV/Core EBITDA(x) | 7.78 | 1.22 | -3.76 |
EV/EBIT(x) | 9.50 | 1.53 | -3.76 |
EV/CE(x) | 1.20 | 0.13 | 0.07 |
M Cap / Sales | 1.28 | - | - |
Growth Ratio | |||
Net Sales Growth(%) | 62.11 | - | - |
Core EBITDA Growth(%) | 64.41 | - | - |
EBIT Growth(%) | 68.42 | - | - |
PAT Growth(%) | 58.28 | - | - |
EPS Growth(%) | -99.56 | - | - |
Financial Stability Ratios | |||
Total Debt/Equity(x) | 0.14 | 0.25 | 0.08 |
Current Ratio(x) | 1.95 | 1.77 | 11.42 |
Quick Ratio(x) | 0.94 | 0.95 | 11.42 |
Interest Cover(x) | 13.39 | 13.99 | - |
Total Debt/Mcap(x) | 0.09 | - | - |
Compare Financial Ratios of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹5,494.0 Cr | 20.2% | 31.8% | 43.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹368,598.0 Cr | 2% | -0.3% | 59.8% | Stock Analytics | |
CIPLA | ₹114,654.0 Cr | 6% | 2.8% | 50.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,348.0 Cr | 3.7% | 5.8% | 17.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,499.0 Cr | 2.6% | 7.9% | 94.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,429.4 Cr | -1.3% | -2.8% | 31.5% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 20.2% |
31.8% |
43.3% |
SENSEX | 1.7% |
-0.8% |
19% |
You may also like the below Video Courses